Public Health Trace

Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters

Drug Recall Terminated Historical recordClass II

fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 250 mL, Total fentaNYL 500 mcg/250 mL, bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2082-2

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated: July 17, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

ketamine in 0.9% sodium chloride, 50 mg/5mL (10mg/mL), 5 mL syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-3022-1

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated: July 17, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

morphine in 0.9% sodium chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2040-3

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated: July 17, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-7

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated: July 17, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

HYDROmorphone in 0.9% sodium chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2012-1

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated: July 17, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

HYDROmorphone in Dextrose 5%, 0.5 mg/5 mL (0.1 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2013-1

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated: July 17, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL in 0.9% sodium chloride, 500 mcg/50 mL, (10 mcg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-3

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated: July 17, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL in 0.9% sodium chloride, 100 mcg/10 mL, (10 mcg/mL), 10 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2071-2

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated: July 17, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-3

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated: July 17, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-2

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated: July 17, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

fentaNYL, 100 mcg/2 mL, (50 mcg/mL), 3 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-1

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated: July 17, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

HYDROmorphone in 0.9% sodium chloride, 6 mg/30 mL, (0.2 mg/mL), 30 mL Syringe, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2010-1

by Central Admixture Pharmacy Services Inc

Reason: Lack of assurance of sterility: Lack of validation data for sanitization cycles
Recall initiated: July 17, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CARDIOPLEGIA SOLUTION, 36 mEq K, Maintenance 8:1, low Potassium / low dextrose, IV Bag, total volume = 500 mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0108-1

by Central Admixture Pharmacy Services, Inc.

Reason: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated: July 14, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CARDIOPLEGIA SOLUTION, low K, Maintenance 4:1 Plasmalyte/Tromethamine, Low Potassium, IV Bag, total volume = 1000 mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0112-1

by Central Admixture Pharmacy Services, Inc.

Reason: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated: July 14, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Cardioplegia Solution, low K, Maintenance 4:1 Plasmalyte, Low Potassium, IV Bag, total volume = 1047 mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0211-1

by Central Admixture Pharmacy Services, Inc.

Reason: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated: July 14, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CARDIOPLEGIA SOLUTION, 12 mEq K, Maintenance 4:1 in Ringer's Low Potassium, IV Bag, total volume = 504.8 mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0205-1

by Central Admixture Pharmacy Services, Inc.

Reason: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated: July 14, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CARDIOPLEGIA SOLUTION, 70 mEq K, Induction 8:1, non-enriched, High Potassium, IV Bag, Total Volume = 300 mL, RX only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0214-1

by Central Admixture Pharmacy Services, Inc.

Reason: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated: July 14, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CARDIOPLEGIA SOLUTION, 70 mEq K, Modified St. Thomas Formula low potassium, IV Bag, Total Volume = 1000 mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0210-1

by Central Admixture Pharmacy Services, Inc.

Reason: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated: July 14, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CARDIOPLEGIA SOLUTION, 106 mEq K, Modified St. Thomas Solution High Potassium High Sodium Bicarbonate, IV Bag, Total Volume = 1000 mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0204-1

by Central Admixture Pharmacy Services, Inc.

Reason: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated: July 14, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CARDIOPLEGIA SOLUTION, 60 mEq K, Induction 4:1, High Potassium, IV Bag, total volume = 830 mL, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0100-1

by Central Admixture Pharmacy Services, Inc.

Reason: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Recall initiated: July 14, 2023
Reported by FDA: August 9, 2023
Distribution: Nationwide in the USA

View recall →

Data last updated: November 1, 2026 ET

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.